All News #Library
Rare Diseases
Viking Therapeutics Reports Q1 2025 Financial Results & Update
23 Apr 2025 //
PR NEWSWIRE
USFDA grants orphan drug status to Viking Therapeutics` VK0214
08 Dec 2016 //
PHARMABIZ

Market Place
Sourcing Support